ChromaDex Corp. financial data

Symbol
CDXC on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
10900 Wilshire Blvd, Suite 600, Los Angeles, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CODY RESOURCES, INC. (to 6/24/2008)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 252 % +2.37%
Quick Ratio 66.1 % -12.1%
Debt-to-equity 87.6 % -9.76%
Return On Equity -4.68 % +81.1%
Return On Assets -2.5 % +80.2%
Operating Margin -2.69 % +75.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 75.9M shares +1.2%
Common Stock, Shares, Outstanding 75.5M shares +0.82%
Entity Public Float 81.1M USD +2.4%
Common Stock, Value, Issued 75K USD 0%
Weighted Average Number of Shares Outstanding, Basic 75.6M shares +0.79%
Weighted Average Number of Shares Outstanding, Diluted 75.6M shares +0.79%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 85.6M USD +5.74%
Cost of Revenue 33.5M USD +2.09%
Research and Development Expense 5.81M USD +14.8%
Selling and Marketing Expense 26.3M USD +1.26%
General and Administrative Expense 22.3M USD -13.9%
Operating Income (Loss) -2.3M USD +73.8%
Net Income (Loss) Attributable to Parent -1.35M USD +79.2%
Earnings Per Share, Basic -0.02 USD/shares +80%
Earnings Per Share, Diluted -0.02 USD/shares +80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.7M USD +5.32%
Accounts Receivable, after Allowance for Credit Loss, Current 7.82M USD
Inventory, Net 11.5M USD -3.86%
Assets, Current 49.3M USD +6.3%
Operating Lease, Right-of-Use Asset 2.06M USD -35.1%
Intangible Assets, Net (Excluding Goodwill) 435K USD -26.4%
Other Assets, Noncurrent 394K USD -23.9%
Assets 54M USD +1.63%
Accounts Payable, Current 8.11M USD -19.2%
Accrued Liabilities, Current 8.62M USD +6.71%
Liabilities, Current 17.9M USD -6.26%
Contract with Customer, Liability, Noncurrent 3.31M USD -13%
Operating Lease, Liability, Noncurrent 2.13M USD -32%
Liabilities 23.3M USD -10.4%
Retained Earnings (Accumulated Deficit) -191M USD -0.71%
Stockholders' Equity Attributable to Parent 30.7M USD +13.1%
Liabilities and Equity 54M USD +1.63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 295K USD -89.4%
Net Cash Provided by (Used in) Financing Activities -14K USD
Net Cash Provided by (Used in) Investing Activities -41K USD +54.9%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 75.5M shares +0.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 240K USD -91.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.9M USD +5.6%
Deferred Tax Assets, Valuation Allowance 46.4M USD +0.3%
Deferred Tax Assets, Gross 46.7M USD +0.51%
Operating Lease, Liability 3.11M USD -20.6%
Depreciation 178K USD -21.9%
Lessee, Operating Lease, Liability, to be Paid 3.35M USD -25.1%
Operating Lease, Liability, Current 973K USD +25.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 901K USD -20.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD +3.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 246K USD -56.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 491K USD -45.5%
Deferred Tax Assets, Operating Loss Carryforwards 36.7M USD -1.54%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 358K USD -27.1%
Operating Lease, Payments 91K USD -49.4%
Additional Paid in Capital 222M USD +2.27%
Amortization of Intangible Assets 38K USD -7.32%
Deferred Tax Assets, Net of Valuation Allowance 358K USD +39.3%
Interest Expense 32K USD -48.4%